Shanxi Zhendong Pharmaceutical - Asset Resilience Ratio

Latest as of September 2025: 10.74%

Shanxi Zhendong Pharmaceutical (300158) has an Asset Resilience Ratio of 10.74% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥484.61 Million

≈ $70.91 Million USD Cash + Short-term Investments

Total Assets

CN¥4.51 Billion

≈ $660.15 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Shanxi Zhendong Pharmaceutical's Asset Resilience Ratio has changed over time. Check asset allocation strategy of Shanxi Zhendong Pharmaceutical to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Shanxi Zhendong Pharmaceutical's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300158 market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥484.61 Million	10.74%
Total Liquid Assets	CN¥484.61 Million	10.74%

Asset Resilience Insights

Moderate Liquidity: Shanxi Zhendong Pharmaceutical has 10.74% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Shanxi Zhendong Pharmaceutical Industry Peers by Asset Resilience Ratio

Compare Shanxi Zhendong Pharmaceutical's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Alkem Laboratories Limited NSE:ALKEM	Drug Manufacturers - Specialty & Generic	31.91%
Beijing Tongrentang Co Ltd SHG:600085	Drug Manufacturers - Specialty & Generic	0.50%
Jiangsu Nhwa Pharmaceutical Co Ltd SHE:002262	Drug Manufacturers - Specialty & Generic	28.06%
Jilin Aodong Pharmaceutical Group Co Ltd SHE:000623	Drug Manufacturers - Specialty & Generic	4.97%
Fujian Cosunter Pharmaceutical Co Ltd SHE:300436	Drug Manufacturers - Specialty & Generic	-2.56%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Zhejiang Medicine Co Ltd SHG:600216	Drug Manufacturers - Specialty & Generic	1.85%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%

Annual Asset Resilience Ratio for Shanxi Zhendong Pharmaceutical (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Shanxi Zhendong Pharmaceutical.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	19.86%	CN¥989.62 Million ≈ $144.81 Million	CN¥4.98 Billion ≈ $729.13 Million	-3.57pp
2023-12-31	23.43%	CN¥1.45 Billion ≈ $211.88 Million	CN¥6.18 Billion ≈ $904.40 Million	-7.40pp
2022-12-31	30.82%	CN¥2.02 Billion ≈ $295.48 Million	CN¥6.55 Billion ≈ $958.60 Million	-13.46pp
2021-12-31	44.28%	CN¥4.47 Billion ≈ $654.06 Million	CN¥10.09 Billion ≈ $1.48 Billion	+43.99pp
2019-12-31	0.29%	CN¥20.00 Million ≈ $2.93 Million	CN¥6.92 Billion ≈ $1.01 Billion	-0.53pp
2018-12-31	0.82%	CN¥59.21 Million ≈ $8.66 Million	CN¥7.21 Billion ≈ $1.06 Billion	+0.15pp
2017-12-31	0.67%	CN¥51.20 Million ≈ $7.49 Million	CN¥7.61 Billion ≈ $1.11 Billion	-0.34pp
2016-12-31	1.02%	CN¥69.86 Million ≈ $10.22 Million	CN¥6.87 Billion ≈ $1.01 Billion	--

pp = percentage points

About Shanxi Zhendong Pharmaceutical

SHE:300158 China Drug Manufacturers - Specialty & Generic

Market Cap

$731.83 Million

CN¥5.00 Billion CNY

Market Cap Rank

#10245 Global

#2691 in China

Share Price

CN¥5.04

Change (1 day)

+1.41%

52-Week Range

CN¥4.57 - CN¥9.45

All Time High

CN¥12.00